Khan Najat bought RXRX
November 5, 2025 · Form 4 insider transaction
Khan Najat bought 169,851 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
169,851
Price
$0.00
Total value
N/A
InsiderKhan Najat
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateNovember 5, 2025
Filing dateNovember 6, 2025
Shares owned after169,851
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on December 5, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.